About us

Anumana, Inc.™ is a health technology company from nference and Mayo Clinic Platform, harnessing industry-leading AI and translational science to decode the electrocardiogram as never before – as a deep predictive tool and biomarker of disease – empowering care providers to help patients early.

Anumana algorithms have been developed, trained, and validated using clinical data from Mayo Clinic, and leverages the powerful augmented intelligence software from nference, nferX®. Anumana is developing AI-enabled ECG algorithms for real-world physician use, integrating point-of-care applications into existing workflows, thereby reducing costs, improving outcomes, and enhancing quality of life. Anumana’s AI-enabled tools can diagnose hidden conditions earlier than ever before. Anumana’s algorithms are investigational medical devices and have not yet received regulatory approval or clearance. For more information, follow Anumana on LinkedIn and Twitter.

Leadership

Murali Aravamudan

Chief Executive Officer

David McMullin

Chief Business Officer

Samir Awasthi, MD, PhD

Vice President of Clinical Research

Rakesh Barve, PhD

Vice President of Data Science and Engineering

Tyler Wagner, PhD

Vice President of Biomedical Research

Hutch Fishman

Chief Financial Officer

Advisors

Paul Friedman, MD

Chair of the Department of Cardiovascular Medicine at Mayo Clinic

Advisory Board Chair

Samuel J. Asirvatham, MD

Electrophysiologist at Mayo Clinic

Zachi Attia, PhD

Director of Artificial Intelligence in Cardiology at Mayo Clinic

Francisco Lopez-Jiminez, MD, MBA

Chair of the Division of Preventive Cardiology at Mayo Clinic

Rickey Carter, PhD

Leader, Digital Innovation Laboratory at Mayo Clinic

Partner with us!

We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to info@anumana.net

Let's Connect

@2022 Anumana, Inc. All rights reserved.